Frontlight ResearchEarly access
Trial site
Joe Arrington Cancer Research and Treatment Center
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Chronic lymphocytic leukaemia2 trials
- Head and neck cancer2 trials
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 24 trials
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Terminated2 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- BeiGene2 trials
- Pfizer2 trials
- BeOne Medicines1 trial
- Celgene1 trial
- Gilead Sciences1 trial
- and 5 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
Closed trials
Recruiting
Completed
Terminated
Completed
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026